Format:
1 Online-Ressource (278 pages)
Edition:
3rd ed
ISBN:
1118321502
,
1118321529
,
9781118321508
,
9781118321522
,
9781118279298
Content:
Continuous glucose monitoring in youth with type 1 diabetes: 12-month follow-up of the Juvenile Diabetes Research Foundation Continuous Glucose Monitoring randomised trialUse of continuous glucose monitoring in subjects with type 1 diabetes on multiple daily injections versus continuous subcutaneous insulin infusion therapy: a prospective 6-month study; Accuracy and reliability of a subcutaneous continuous glucose-monitoring system in critically ill patients; The effect of real-time continuous glucose monitoring on glycaemic control in patients with type 2 diabetes mellitus.
Content:
Cover; Title Page; Copyright; List of Contributors; Editors; Associate Editors; Preface; CHAPTER 1: Self-Monitoring of Blood Glucose; INTRODUCTION; Non-coding glucometers among paediatric patients with diabetes: looking for the target population and an accuracy evaluation of no-coding personal glucometer; Effect of ambient temperature on analytical performance of self-monitoring blood glucose systems; Association between self-monitoring of blood glucose and diet among minority patients with diabetes; Accuracy and precision evaluation of seven self-monitoring blood glucose systems.
Content:
INTRODUCTIONGlycaemic control in type 1 diabetes during real-time continuous glucose monitoring compared with self-monitoring of blood glucose: meta-analysis of randomised controlled trials using individual patient data; Effect of continuous glucose monitoring on hypoglycaemia in type 1 diabetes; Sensor-augmented pump therapy lowers HbA1c in suboptimally controlled type 1 diabetes; a randomised controlled trial; Sensor-augmented pump therapy from the diagnosis of childhood type 1 diabetes: results of the Paediatric Onset Study (ONSET) after 12 months of treatment.
Content:
Self-monitoring of blood glucose: the use of the first or the second drop of bloodStructured self-monitoring of blood glucose significantly reduces A1C levels in poorly controlled, non-insulin-treated type 2 diabetes: results from the Structured Testing Program study; Estimates of total analytical error in consumer and hospital glucose meters contributed by haematocrit, maltose and ascorbate; Evaluating the cost-effectiveness of self-monitoring of blood glucose in type 2 diabetes patients on oral antidiabetic agents.
Content:
The traditional agents for controlling the levels of glucose in the blood remain important therapies but they have their downside from the point of view of tolerability and side effects. Moreover, they appear not to be able to counter the natural history deterioration of the disease in terms of the onset of diabetic-related complications. Recent years have seen an influx of new treatment therapies and technologies aimed at achieving better glycaemic control for diabetic patients such as liraglutide (Novo Nordisk) and saxagliptin (BMS/Astra-Zeneca) and insulin pumps, away from the more traditio
Content:
Using a cell-phone-based glucose monitoring system for adolescent diabetes managementAccuracy of handheld blood glucose meters at high altitude; Designing mobile support for glycaemic control in patients with diabetes; Immortal time bias and survival in patients who self-monitor blood glucose in the Retrolective Study: Self-monitoring of Blood Glucose and Outcome in Patients with Type 2 Diabetes (ROSSO); Self-monitoring of blood glucose in tablet-treated type 2 diabetic patients (ZODIAC-I7); The accuracy of home glucose meters in hypoglycaemia; CHAPTER 2: Continuous Glucose Monitoring in 2011.
Note:
Includes index
,
Includes bibliographical references and index
,
ATTD 2011 Yearbook; Contents; List of Contributors; Preface; CHAPTER 1 Self-Monitoring of Blood Glucose; CHAPTER 2 Continuous Glucose Monitoring in 2011; CHAPTER 3 Insulin Pumps; CHAPTER 4 Closing the Loop; CHAPTER 5 New Insulins and Insulin Therapy; CHAPTER 6 New Ways of Insulin Delivery; CHAPTER 7 Using Health Information Technology to Prevent and Treat Diabetes; CHAPTER 8 Technology and Pregnancy; CHAPTER 9 Type 1 Diabetes Mellitus: Immune Intervention; CHAPTER 10 Advances in Exercise, Physical Activity and Diabetes Mellitus
,
CHAPTER 11 Diabetes Technology and Treatment in the Paediatric Age GroupCHAPTER 12 Diabetes Technology and the Human Factor; CHAPTER 13 New Medications for the Treatment of Diabetes; Index
Additional Edition:
9781118279298
Additional Edition:
Erscheint auch als Druck-Ausgabe Attd 2011 Year Book John Wiley & Sons Inc 2012 9781118279298
Language:
English
DOI:
10.1002/9781118321508
Bookmarklink
